Labiotech.eu

News and Trends 24 Jan 2017

Smart Nebulizers for Children with Asthma are Underway

Vectura has received FDA approval to start testing a smart device to improve asthma therapies in children. Vectura, based in the UK, develops inhaled delivery technology for diseases that affect air tracts, such as cystic fibrosis, or influenza. The company has now received an investigational new drug (IND) approval from the FDA to study a […]

January 24, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 23 Jan 2017

French Biotech partners with Merck to Fight Tumor Resistance

Domain Therapeutics and Merck have partnered up to develop immuno-oncology drug candidates that can boost the performance of checkpoint inhibitors. Domain Therapeutics has entered a collaboration and licensing agreement with German Merck in immuno-oncology. The big pharma is offering over €240M in milestones and will support research activities in exchange for worldwide rights to new drug candidates targeting […]

January 23, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Screenshot 2017 01 23 at 3.58.16 PM 1 e1485183691824

News and Trends 23 Jan 2017

New Fundraising Boosts Ultra-Rapid STD Detection

Atlas Genetics has raised €32.6M in Series D. The funds will help the company bring ultra-rapid diagnostic tests for STDs to the market. Atlas Genetics, a spin-off from the University of Bath, has closed an impressive €32.6M ($35M) Series D round of fundraising. The funds will support clinical trials, manufacturing and the commercial launch of the company’s second ultra-rapid […]

January 23, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 23 Jan 2017

A Placebo beats the Largest European Biotech in Phase III

Actelion’s lead drug Opsumit has missed its primary endpoint in Phase III. What are the consequences for the biggest independent biotech in Europe? Actelion is a leader in treatments for pulmonary arterial hypertension (PAH). However, results from a Phase III trial evaluating Opsumit (macitentan) in patients with PAH due to Eisenmenger Syndrome have revealed that the drug […]

January 23, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Interview 23 Jan 2017

“Senior Staff Snobbery separates Academia from the Biotech Industry”

We caught up with Mark Lowdell, Director of Cellular Therapeutics and the RFH/UCL Cancer Biobank. As one of the few successful scientist-entrepreneurs, he has some ideas about bridging academia and industry in biomedicine. Mark Lowdell was introduced to me by his business partner, RJ Tesi. Tesi co-founded INmune Bio, a promising California-based startup, on Lowdell’s […]

January 23, 2017 - 6 minutesmins - By Evelyn Warner

Studies of an Alien Skin ANDREAS GREINER 1 e1484759999751

More News! 21 Jan 2017

Giant Chickens and Bioluminiscent Squids Invade Berlin

Andreas Greiner explores the world of living beings we never pay attention to, inviting visitors to reflect on the anthropocentric culture from Western countries. When you enter Andreas Greiner‘s exhibition at the Berlinische Galerie, a giant skeleton of what looks like a dinosaur looms 7 meters tall. A closer inspection reveals that the giant ‘Monument […]

January 21, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 20 Jan 2017

Will Legos go Bio? The Sustainable Future of ‘Greener Toys’

The LEGO group is spending over €100M to replace its current plastic type for a more sustainable one, and there’s a new generation of environmentally-friendly biobased toys cropping up. Are bioplastic toys the future? Lego is an icon, and one with growing power at that. The toy has been adopted as an informal mascot of sorts of STEM […]

January 20, 2017 - 3 minutesmins - By Denise Neves Gameiro

More News! 19 Jan 2017

I heard about these Hot Topics at JPM: Devices, Politics & Personalities

Last week, I had the pleasure of attending one of the smaller satellite events of the JP Morgan biotech conference. Here are some of the day’s themes. The JP Morgan conference extends far beyond the confines of the Westin that hosts the main event with smaller, more specific or exclusive events, networking nights, and happy […]

January 19, 2017 - 4 minutesmins - By External Contributor

Infographics 19 Jan 2017

Infographic: A History of Approved Therapeutic Antibodies

Which are the EMA-approved therapeutic antibodies? How about their targets and indications? The number is growing year after year — here is a timeline. As medicine progresses into a new era of personalized therapy, therapeutic antibodies are leading the charge and have grown into a billion-euro industry. Antibodies present an attractive option for a wide variety […]

January 19, 2017 - 1 minutemin - By Marie Godar

News and Trends 18 Jan 2017

Evotec launches New Biotech to tackle the Most Deadly Diseases

Evotec has backed the foundation of Fibrocor, a Canadian company that will work on fibrosis, the underlying cause of some of the most deadly diseases. Fibrocor was launched yesterday in Toronto with €2M (CDN 2.8M) from the successful German biotech CRO Evotec and the Canadian non-profit MaRS Innovation. Evotec will provide all drug discovery activities […]

January 18, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 18 Jan 2017

New Combo Therapy for Type 2 Diabetes to Sweep Europe

Zealand Pharma and its partner Sanofi have made it to the European market with a new combination therapy to treat type 2 diabetes. Suliqua, a treatment for type 2 diabetes, has received marketing authorization in Europe. This feat has earned Zealand Pharma a €9.4M ($10M) payment from its partner Sanofi. The big pharma is responsible […]

January 18, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 18 Jan 2017

It’s Not Just Regulations: 9 Other Reasons Advanced Therapies Fail

For advanced therapy medicinal products (ATMPs), the regulatory process is a major challenge to reach the market; but it’s only part of the picture. Here are the top 9 other pre-approval reasons these cell and gene therapies fail. Sound Scientific Rationale + Good Product = Successful Outcome.” Paula Salmikangas, Committee for Advanced Therapies (CAT) Chairman […]

January 18, 2017 - 7 minutesmins - By Timothé Cynober

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Smart Nebulizers for Children with Asthma are Underway

French Biotech partners with Merck to Fight Tumor Resistance

New Fundraising Boosts Ultra-Rapid STD Detection

A Placebo beats the Largest European Biotech in Phase III

“Senior Staff Snobbery separates Academia from the Biotech Industry”

Giant Chickens and Bioluminiscent Squids Invade Berlin

Will Legos go Bio? The Sustainable Future of ‘Greener Toys’

I heard about these Hot Topics at JPM: Devices, Politics & Personalities

Infographic: A History of Approved Therapeutic Antibodies

Evotec launches New Biotech to tackle the Most Deadly Diseases

New Combo Therapy for Type 2 Diabetes to Sweep Europe

It’s Not Just Regulations: 9 Other Reasons Advanced Therapies Fail

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!